Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Tan

Showing results (221-230 of 352) with videos related to

Pageof 36
Sort By:
Eye (London, England)|February 28, 2025
Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP)Stanley S J Poh, Kelvin Y C Teo, Rose Ann Goh, et al.
Plos One|October 25, 2014
Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assayCheryl C Y Loh, Rossarin Suwanarusk, Yan Quan Lee, et al.
Stem Cell Research & Therapy|July 28, 2021
Submacular integration of hESC-RPE monolayer xenografts in a surgical non-human primate modelZengping Liu, Tanja Ilmarinen, Gavin S W Tan, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 15, 2025
Real-world outcomes of scleral-fixated intraocular lens: a multi-surgeon study comparing four-point fixation and flanged intrascleral haptic fixation techniquesStanley S J Poh, Shayne S Tan, Andrew S H Tsai, et al.
BMC Cancer|October 25, 2024
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLCArmando Santoro, Garrido Pilar, Daniel S W Tan, et al.
The Oncologist|August 10, 2019
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF AlterationsAditya Bardia, Mrinal Gounder, Jordi Rodon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and CeritinibJustin F Gainor, Daniel S W Tan, Tomasso De Pas, et al.
JCO Precision Oncology|January 27, 2022
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung CancersAlexander Drilon, Daniel S W Tan, Ulrik N Lassen, et al.
Frontiers in Cellular and Infection Microbiology|June 10, 2025
Chloroquine induces eryptosis in <i>P. falciparum</i>-infected red blood cells and the release of extracellular vesicles with a unique protein profileClaudia Carrera-Bravo, Tianchi Zhou, Trang Chu, et al.
JTO Clinical and Research Reports|September 30, 2021
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced <i>ALK</i>-Rearranged NSCLC: An ASCEND-4 Subgroup AnalysisDaniel S W Tan, Sarayut Geater, Chong-Jen Yu, et al.
Pageof 36

Showing results (221-230 of 352) with videos related to

Sort By:
Pageof 36
Eye (London, England)|February 28, 2025
Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP)Stanley S J Poh, Kelvin Y C Teo, Rose Ann Goh, et al.
Plos One|October 25, 2014
Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assayCheryl C Y Loh, Rossarin Suwanarusk, Yan Quan Lee, et al.
Stem Cell Research & Therapy|July 28, 2021
Submacular integration of hESC-RPE monolayer xenografts in a surgical non-human primate modelZengping Liu, Tanja Ilmarinen, Gavin S W Tan, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 15, 2025
Real-world outcomes of scleral-fixated intraocular lens: a multi-surgeon study comparing four-point fixation and flanged intrascleral haptic fixation techniquesStanley S J Poh, Shayne S Tan, Andrew S H Tsai, et al.
BMC Cancer|October 25, 2024
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLCArmando Santoro, Garrido Pilar, Daniel S W Tan, et al.
The Oncologist|August 10, 2019
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF AlterationsAditya Bardia, Mrinal Gounder, Jordi Rodon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and CeritinibJustin F Gainor, Daniel S W Tan, Tomasso De Pas, et al.
JCO Precision Oncology|January 27, 2022
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung CancersAlexander Drilon, Daniel S W Tan, Ulrik N Lassen, et al.
Frontiers in Cellular and Infection Microbiology|June 10, 2025
Chloroquine induces eryptosis in <i>P. falciparum</i>-infected red blood cells and the release of extracellular vesicles with a unique protein profileClaudia Carrera-Bravo, Tianchi Zhou, Trang Chu, et al.
JTO Clinical and Research Reports|September 30, 2021
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced <i>ALK</i>-Rearranged NSCLC: An ASCEND-4 Subgroup AnalysisDaniel S W Tan, Sarayut Geater, Chong-Jen Yu, et al.
Pageof 36